| FORMYCON AG |
| Deutschland |
| Gesundheit |
| DE000A1EWVY8 / A1EWVY |
| FYB (Frankfurt) |
| FRA:FYB, ETR:FYB, FYB:GR |
| - |
| https://www.formycon.com/ |
|
Formycon AG is a leading independent biotechnology company headquartered in Planegg, Germany, specializing in the development of high-quality biosimilars, which are cost-effective follow-on versions o..
>Volltext.. |
| 301.79 Mio. EUR |
| 284.7 Mio. EUR |
| 52.71 Mio. EUR |
| -14.45 Mio. EUR |
| -172.82 Mio. EUR |
| -9.78 EUR |
| 10.39 Mio. EUR |
| 27.77 Mio. EUR |
| 14.93 Mio. EUR |
| 0.67 |
| -14.84% |
| -365.69% |
| - |
| - |
| - |
| - |
| FORMYCON, NANOHALE |
| 23.03.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|